Metformin + Berberine Interaction

⚠️ RESEARCH-BASED INTERACTION DATA — NOT COMPREHENSIVE.

Interaction Type: caution | Evidence Level: moderate

Metformin and berberine both activate AMPK via mitochondrial Complex I inhibition. Concurrent use may cause excessive AMPK activation and increase lactic acidosis risk.

Mechanism of Interaction

Both metformin and berberine inhibit mitochondrial Complex I, raising the AMP:ATP ratio and activating AMPK. This shared mechanism means the combination could produce additive or supra-additive Complex I inhibition, potentially impairing mitochondrial ATP production and increasing lactate accumulation.

Clinical Relevance

While both are studied as glucose-lowering agents, combining them is generally not recommended due to overlapping mechanisms. Berberine is sometimes called 'natural metformin' — the combination essentially doubles the mechanism. Some practitioners use one OR the other, not both.

Recommendations

• Generally avoid concurrent use — overlapping mechanisms with increased risk
• If combining, use reduced doses of each and monitor closely
• Check lactic acid levels if symptoms of malaise, muscle pain, or hyperventilation
• Choose one or the other for AMPK activation strategy

Relevant Conditions

• Type 2 diabetes / metabolic syndrome
• Cancer metabolic therapy
• Longevity protocols